Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

8/10/12 mg qd, po. Stop the medication for one week after taking it for two weeks.

8/12 mg qd, po.

0.4 g bid, po.

0.3 g bid, po.

10 mg qd, po.

500 mg qd, po.

Dabrafenib 150 mg bid, po+Trametinib 2 mg qd, po.

Cabozantinib 60mg qd, po.

Vandetanib 300mg qd, po.

Entrectinib 600mg qd，po.

400mg qd, po.

100mg qd，po